Additional file 1 of The largest meta-analysis on the global prevalence of microsporidia in mammals, avian and water provides insights into the epidemic features of these ubiquitous pathogens
Creators: name: Ruan, Yingfei
name: Xu, Xiaofei
name: He, Qiang
name: Li, Li
name: Guo, Junrui
name: Bao, Jialing
name: Pan, Guoqing
name: Li, Tian
name: Zhou, Zeyang
Publisher: name: figshare
Year: 2021
Subjects: subject: Biotechnology
subject: Environmental Sciences not elsewhere classified
subject: Ecology
subject: FOS: Biological sciences
subject: Biological Sciences not elsewhere classified
subject: Cancer
subject: Infectious Diseases
subject: FOS: Health sciences

description: Additional file 1: Figure S1. Forest plot diagram showing the prevalence of Encephalitozoon infection in humans. Figure S2. Forest plot diagram showing microsporidian infection in humans of different genders. Figure S3. Forest plot diagram showing microsporidian infection in humans of different age groups. Figure S4. Forest plot diagram showing microsporidian infection in humans of different regions. Figure S5. Forest plot diagram showing microsporidian infection in humans of different income levels. Figure S6. Forest plot diagram showing microsporidian infection in humans with different CD4 cell counts. Figure S7. Forest plot diagram showing microsporidian infection in humans with diarrhea. Figure S8. Forest plot diagram showing the coinfection prevalence rate of microsporidia and Cryptosporidium in humans. Figure S9. Forest plot diagram showing the prevalence of microsporidian infection in different species of swine. Figure S10. Forest plot diagram showing the prevalence of microsporidian infection in different age groups of swine. Figure S11. Forest plot diagram showing the prevalence of microsporidian infection in cats. Figure S12. Forest plot diagram showing the prevalence of microsporidian infection in pet and feral cats. Figure S13. Forest plot diagram showing the prevalence of microsporidian infection in dogs. Figure S14. Forest plot diagram showing the prevalence of microsporidian infection in pet and feral dogs. Figure S15. Forest plot diagram showing the prevalence of microsporidian infection in Bos. Figure S16. Forest plot diagram showing the prevalence of microsporidian infection in Ovis. Figure S17. Forest plot diagram showing the prevalence of microsporidian infection in deer. Figure S18. Forest plot diagram showing the prevalence of microsporidian infection in horses. Figure S19. Forest plot diagram showing the prevalence of microsporidian infection in nonhuman primates. Figure S20. Forest plot diagram showing the prevalence of microsporidian infection in farm-raised and wild nonhuman primates. Figure S21. Forest plot diagram showing the prevalence of microsporidian infection in birds. Figure S22. Forest plot diagram showing the prevalence of microsporidian infection in wild and domestic birds. Figure S23. Forest plot diagram showing the prevalence of microsporidian infection in land and amphibious birds. Figure S24. Forest plot diagram showing the prevalence of microsporidian infection in rodents. Figure S25. Forest plot diagram showing the prevalence of microsporidian infection in water. Figure S26. Forest plot diagram showing the prevalence of microsporidian infection in different water sources. Table S1. Included studies of microsporidian infection in humans. Table S2. Included studies of microsporidian coinfection in humans. Table S3. Included studies of microsporidian infection in swine. Table S4. Included studies of microsporidian infection in cats and dogs. Table S5. Included studies of microsporidian infection in ruminants. Table S6. Included studies of microsporidian infection in nonhuman primates. Table S7. Included studies of microsporidian infection in other mammals. Table S8. Included studies of microsporidian infection in birds. Table S9. Included studies of microsporidia in water. Table S10. Checklist of items included when reporting a meta-analysis.